|
|
 |
|
Viewing report
|
|
|
|
Alopecia Therapeutics - Pipeline Assessment and Market Forecasts to 2017
GlobalData, Sep 2011, Pages: 67
Alopecia Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Summary
GlobalData, the industry analysis specialist, has released its new report, “Alopecia Therapeutics - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global alopecia market. The report identifies the key trends shaping and driving the global alopecia market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global alopecia sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
GlobalData has estimated the global alopecia therapeutics market to be valued at $2,014.9m in 2010. It is forecast to grow at a CAGR (Compound Annual Growth Rate) of 4.8% for the next seven years to reach $2,804.4m by 2017. The market grew at a CAGR of 8.4% during the historic period (2005-2010). Propecia (finasteride) and Rogaine (minoxidil) are the only prescribed drugs for the treatment of alopecia. The patent expiry of Propecia in 2013 will impact the alopecia therapeutic market in the forecast period. However, Avodart (5a-reductase inhibitor) from GlaxoSmithKline which is an analogue to Propecia is in Phase III trials, and the drug is expected to launch by 2016. The major breakthrough in the Japan alopecia therapeutics market in the historical period was the approval of Propecia in 2006. The increasing patient population and expected launch of new drugs during the forecast period will drive the market growth.
Scope
The report provides information on the key drivers and challenges of the alopecia market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) alopecia market revenues data from 2005 to 2010, forecast for seven years to 2017.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes such as androgen receptor antagonist, 5-alphareductase inhibitor, fatty acid derivative, immunosuppressant, potassium channel opener and prostaglandin agonist.
- Analysis of the current and future competition in the seven key countries alopecia market. Key market players covered are GlaxoSmithKline, Johnson & Johnson, Allergan, Cosmo Pharmaceuticals and R-Tech Ueno.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the alopecia market.
- Analysis of key recent licensing and partnership agreements in alopecia market
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global alopecia market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global alopecia market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global alopecia market landscape? – Identify, understand and capitalize.
|
|
|
|
